Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05877742
Other study ID # AA-drug abusers
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 20, 2023
Est. completion date May 20, 2024

Study information

Verified date May 2023
Source The Hong Kong Polytechnic University
Contact Ka Wai Katherine Lam
Phone 27666420
Email kw-katherine.lam@polyu.edu.hk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Drug abuse is a serious public health issue. Despite the serious consequences of drug abuse, there are around 2000 new cases reported by drug abusers each year. There is growing evidence of the use of auricular acupressure (AA), a traditional Chinese medicine (TCM) treatment modality, in reducing withdrawal symptoms among drug abusers. This study aims to investigate the feasibility and effectiveness of training nursing students to deliver brief education on AA on drug abusers.


Description:

A 2-arm feasibility cluster RCT will be conducted in the 80 drug abusers from 7 substance abuse clinics in Hong Kong Hospital Authority following the CONSORT statement. The intervention group will receive AA intervention individually from trained nursing students. The control group will individually receive a 5-minute seminar delivered by a research assistant.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date May 20, 2024
Est. primary completion date May 20, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Aged 18 or above - Have reported to abuse drugs within the past 30 days - Can communicate in Cantonese and read Chinese Exclusion Criteria: - Unstable mental conditions that are not suitable for the intervention - Receiving acupuncture or acupressure treatment currently or in the previous 30 days

Study Design


Related Conditions & MeSH terms


Intervention

Other:
AA group
Participants will individually receive a 5-minute AA education delivered verbally at his/her respective clinic by a trained nursing student interventionist in addition to the usual scheduled follow-ups and activities at clinics.
Control group
To mimic the time and attention spent, the control group will individually receive a 5-minute seminar delivered by an RA.

Locations

Country Name City State
Hong Kong Katherine Lam Hong Kong Hong Kong,China

Sponsors (1)

Lead Sponsor Collaborator
The Hong Kong Polytechnic University

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Screening rate calculated as the number of abusers screened at participated clinics divided by number of abusers at participated clinics during the recruitment period. at the 6-month follow-up
Primary Eligibility rate calculated by dividing the number of abusers who are eligible by the number who are screened. at the 6-month follow-up
Primary Consent rate calculated by dividing the number of abusers who consent to join the study by the number who are eligible. at the 6-month follow-up
Primary Randomization rate calculated by dividing the number of abusers who are randomized into intervention and control groups by those who provide consent. at the 6-month follow-up
Primary Attendance rate calculated by dividing the number of abusers who complete the intervention by those who are randomized. at the 6-month follow-up
Primary Retention rate : calculated by dividing the number of abusers who remain in the study by those who are randomized. Retention rates for the intervention and control groups will be calculated at each follow-up. at the 6-month follow-up
Primary Adherence to intervention protocol calculated by dividing the number of abusers who follow the intervention protocol by those who are randomized. at the 6-month follow-up
Primary Complete rate calculated by dividing the number of abusers who returned questionnaires by the number of questionnaires distributed. This will be calculated by groups at baseline and each follow-up. at the 6-month follow-up
Primary Missing data calculated as the percentage of missing values in the dataset. Unknown or blank values will be considered missing values. at the 6-month follow-up
Primary Adverse events defined as unfavorable and unintended events that are not present at baseline, or appear to have worsened during the study. at the 6-month follow-up
Secondary Self-reported abstinence Self-reported drug abstinence at last 30 days. at the 6-month follow-up
Secondary Abstinence with urine testing . Those who report no drug abuse within the past 30 days at the 6-month follow-up will be further invited for urine testing. at the 6-month follow-up
Secondary Self-reported levels of craving The Chinese version of the 3-item craving scale will be used to measure abusers' self-reported levels of craving. at the 6-month follow-up
Secondary Anxiety Generalized anxiety disorder-7 will be used to measure the severity of self-reported anxiety. at the 6-month follow-up
Secondary Quality of life measures by short-Form Six-Dimension Short-Form Six-Dimension will be used to assess abusers' quality of life.It contains six dimensions of health. The Chinese version is well validated in Hong Kong. at the 6-month follow-up
See also
  Status Clinical Trial Phase
Completed NCT02224508 - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks N/A
Completed NCT02282306 - Phone Interview to Prevent Recurring Opioid Overdoses N/A
Completed NCT02375516 - Preventing Drug Abuse Among Hispanic Adolescents N/A
Completed NCT01442753 - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth N/A
Withdrawn NCT01275391 - cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use Phase 1/Phase 2
Completed NCT00907309 - Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use Phase 1/Phase 2
Completed NCT02228044 - Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment N/A
Withdrawn NCT01427465 - Brief Integrative Alcohol Interventions for Adolescents N/A
Completed NCT00350909 - Brief Intervention for Drug Abusing Adolescents Phase 2
Completed NCT00148031 - Improving Hepatitis C Treatment in Injection Drug Users Phase 4
Completed NCT00383838 - Self-Selected Brief Alcohol Intervention for Adolescents N/A
Completed NCT00722644 - Cognitive Behavioral Stress Management for HIV+ Drug Abusers Phase 1
Completed NCT00451854 - Student Athlete Testing Using Random Notification N/A
Completed NCT01036711 - Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRI
Terminated NCT02741076 - Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain Phase 4
Completed NCT01035723 - Effect of Functional Genetic Polymorphisms on Brain Morphology and Function
Completed NCT06044363 - Satir Model for Self-esteem, Mental Health, and Family Function Among Individuals With Substance Use Disorders N/A
Recruiting NCT05037487 - Evaluation of Smoked THC and CBD in Men and Women Phase 1
Recruiting NCT04725266 - A Family-based Intervention for Drug-abusing Adults in Hong Kong N/A
Completed NCT03678051 - CBT4CBT for Women in Residential Treatment for Substance Use Disorders N/A